[Answered] For discharge services of a patient in a nursing facility, code 99315 or ___________________

This topic contains a solution. Click here to go to the answer

Author Question: For discharge services of a patient in a nursing facility, code 99315 or ____________________ can be ... (Read 97 times)

karateprodigy

Hero Member
Posts: 550

on: Jun 27, 2018

For discharge services of a patient in a nursing facility, code 99315 or ___________________ _ can be assigned.
Fill in the blank(s) with correct word

Question 2

Hospital discharge-day management of 45 minutes is reported with the CPT code ___________________ _.
Fill in the blank(s) with correct word

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

wshriver

Sr. Member
Posts: 318

Reply #1 on: Jun 27, 2018

Answer to Question 1

99316

Answer to Question 2

99239

karateprodigy

Member
Posts: 550

Reply 2 on: Jun 27, 2018

TYSM

okolip

Member
Posts: 362

Reply 3 on: Yesterday

Wow, this really help

« previous next »

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.